The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC)(MOUNTAINEER).
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Celgene; Genentech/Roche; Onyx
Research Funding - Abbvie (Inst); Bayer (Inst); Exelixis (Inst); Gilead Sciences (Inst); MedImmune (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Donna Niedzwiecki
No Relationships to Disclose
 
Tyler Zemla
No Relationships to Disclose
 
Andrea Cercek
Consulting or Advisory Role - Amgen; Bayer
Research Funding - Abbvie (Inst); Amgen; Bayer (Inst)
 
Marwan Fakih
Honoraria - Sirtex Medical
Consulting or Advisory Role - Amgen; Array BioPharma; Genentech/Roche; Merck; Sirtex Medical
Speakers' Bureau - Sirtex Medical
Research Funding - Amgen (Inst); Novartis (Inst)
 
Kimmie Ng
Honoraria - Prime Oncology; Sage Publications
Consulting or Advisory Role - Defined Health; Genentech/Roche
Research Funding - Celgene; Genentech/Roche (Inst); Gilead Sciences; Pharmavite (Inst); Trovagene
 
Federico Augusto Sanchez
Consulting or Advisory Role - Via Oncology
 
Christina Sing-Ying Wu
Honoraria - BioTheranostics
Consulting or Advisory Role - Bayer
Research Funding - Amgen
Travel, Accommodations, Expenses - Merck
 
Scott Peterson
Employment - Cascadian Therapeutics
 
Lorelei Bandel
No Relationships to Disclose
 
Axel Grothey
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Glenmark; Lilly; Merrimack; NCCN; Regeneron; Research to Practice; Taiho Pharmaceutical
Research Funding - NCCN; NCI; Oncolytics
Expert Testimony - Helsinn Therapeutics
Other Relationship - ARMO BioSciences; Exelixis; Exelixis; Merck; Polaris; Sillajen